<?xml version="1.0" encoding="UTF-8"?>
<p>Overall assessment. Magnolia bark has been used in Chinese and Japanese traditional medicines for the treatment of asthma, allergic disease, as well as for the alleviation of headaches, muscular pain, and fever (
 <xref rid="B194" ref-type="bibr">Forrest, 1995</xref>; 
 <xref rid="B296" ref-type="bibr">Lee et al., 2011</xref>). As 
 <italic>M. officinalis</italic> preparations are not clinically proven to provide symptomatic relief of flu symptoms and its active principle (magnolol) may enhance the entry SARS-CoV-2 virus into the cell, the clinical evidence may be considered Medium and the safety, in the COVID-19 context, Medium.
</p>
